Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
December 11, 2019

Amneal to buy generic pharmaceuticals provider AvKAR for $340m

Amneal Pharmaceuticals has signed an agreement to acquire a majority stake in generic pharmaceuticals provider AvKARE for an implied enterprise value of $340m.

Image: Amneal agrees to acquire generic pharmaceuticals provider AvKAR. Photo: courtesy of Jamal Abdul Nasir from Pixabay.